Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Kathrin Wildenberger, Christine Günther, Michael Cross, PhD, Thomas Ernst, MD, Christian Fabisch, PhD, Dietger Niederwieser, MD, Andreas Hochhaus, MD, Thoralf Lange, MD

Blood (2017) 130 (Supplement 1): 252.

https://doi.org/10.1182/blood.V130.Suppl_1.252.252

Published: 2017

Journal Articles

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

Madlen Jentzsch, MD, Marius Bill, MDPhD, Julia Schulz, Juliane Grimm, Stefanie Beinicke, Karoline Schubert, Janine Haentschel, Kathrin Wildenberger, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 517.

https://doi.org/10.1182/blood.V128.22.517.517

Published: 2016

Journal Articles

Increasing the Sensitivity of BCR-ABL Monitoring By Digital PCR By Reducing the Background Noise

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Svilen Tzonev, PhD, Dawne Naomi Shelton, PhD, Michael Cross, PhD, Kathrin Wildenberger, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2016) 128 (22): 3085.

https://doi.org/10.1182/blood.V128.22.3085.3085

Published: 2016

Journal Articles

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Kathrin Wildenberger, Michael Cross, PhD, Oliver Frank, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Christian T. Dietz, PhD, Martin C. Müller, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2015) 126 (23): 135.

https://doi.org/10.1182/blood.V126.23.135.135

Published: 2015

Journal Articles

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Sebastian Schwind, MD, Madlen Jentzsch, MD, Marius Bill, PhD, Karoline Schubert, Laura Schmalbrock, Heike Weidner, Laura Kloss, Taqiuddine Gaber, Lynn Bonifacio, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 732.

https://doi.org/10.1182/blood.V124.21.732.732

Published: 2014

Journal Articles

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Karoline Schubert, Michael Cross, PhD, Sabine Leiblein, Kathrin Wildenberger, Frank Giles, MDMB, Andreas Hochhaus, MD, Oliver Frank, PhD, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2014) 124 (21): 3143.

https://doi.org/10.1182/blood.V124.21.3143.3143

Published: 2014

Journal Articles

The Prognostic Impact of the Mutational Profile in Patients with Myelofibrosis in the Era of the JAK1/JAK2-Inhibitor Ruxolitinib

Haifa Kathrin Al-Ali, MD, Song-Yau Wang, Nadja Jaekel, MD, Anne Koehler, MD, Rainer Krahl, PhD, Karolin Hubert, Mrs, Thoralf Lange, MD, Martin Roskos, PhD, Rayak Stengel, PhD, Ines Kovacs, Mrs, Schwabe Scarlett, Mrs, Karoline Schubert, Kathrin Wildenberger, Melanie Schneider, Mrs, Elisabeth Koehler, Mrs, Dietger Niederwieser, MD

Blood (2014) 124 (21): 1860.

https://doi.org/10.1182/blood.V124.21.1860.1860

Published: 2014

Journal Articles

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

Taqiuddine Gaber, Marius Bill, PhD, Madlen Jentzsch, MD, Karoline Schubert, Heike Weidner, Laura Kloss, Laura Schmalbrock, Bonifacio Lynn, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2014) 124 (21): 1037.

https://doi.org/10.1182/blood.V124.21.1037.1037

Published: 2014

Journal Articles

A Comparison of Droplet Digital PCR and Quantitative RT-PCR for Low Level BCR-ABL in CML Patients with Molecular Responses

Jacqueline Maier, PhD, Georg-Nikolaus Franke, MD, Karoline Schubert, Kathrin Wildenberger, Michael Cross, PhD, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2014) 124 (21): 1792.

https://doi.org/10.1182/blood.V124.21.1792.1792

Published: 2014

Journal Articles

High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia

Heike Weidner, Marius Bill, PhD, Laura Schmalbrock, Madlen Jentzsch, MD, Laura Kloss, Taqiuddine Gaber, Lynn Bonifacio, MD, Karoline Schubert, Kathrin Wildenberger, Dennis Gerloff, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Stephan Fricke, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2014) 124 (21): 1575.

https://doi.org/10.1182/blood.V124.21.1575.1575

Published: 2014

Journal Articles

Low Level BCR-ABL Mutations Below the Detection Limit of Current Standard Screening Techniques Occur Predominantly in the CD34+ Progenitor Cell Compartment in Chronic Phase CML Patients At Diagnosis. A Substudy of the ENEST1st Trial

Jacqueline Maier, Karoline Schubert, Michael Cross, PhD, Sabine Leiblein, Kathrin Wildenberger, Frank Giles, MD, Andreas Hochhaus, MD, Oliver Frank, Dietger Niederwieser, Thoralf Lange

Blood (2012) 120 (21): 1671.

https://doi.org/10.1182/blood.V120.21.1671.1671

Published: 2012

Journal Articles

BCR-ABL Kinase Domain Mutations in the P-Loop and at Imatinib Contact Sites in CML Patients with Imatinib Resistance Are Associated with Higher Maximum Imatinib Doses.

Oliver Pelz-Ackermann, Michael W.N. Deininger, PhD, Michael Cross, PhD, Kathrin Wildenberger, Rainer Krahl, PhD, Song-Yau Wang, MD, Haifa K. Al-Ali, MD, Dietger W. Niederwieser, MD, Thoralf Lange, MD

Blood (2007) 110 (11): 2918.

https://doi.org/10.1182/blood.V110.11.2918.2918

Published: 2007

NARROW

Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

Increasing the Sensitivity of BCR-ABL Monitoring By Digital PCR By Reducing the Background Noise

Quantification of BCR-ABL with Digital PCR Results in a Significantly Lower Rate of Deep Molecular Responses When Compared to RT-qPCR in CML Patients Treated in the ENEST1st Trial

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

The Prognostic Impact of the Mutational Profile in Patients with Myelofibrosis in the Era of the JAK1/JAK2-Inhibitor Ruxolitinib

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

A Comparison of Droplet Digital PCR and Quantitative RT-PCR for Low Level BCR-ABL in CML Patients with Molecular Responses

High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia

Low Level BCR-ABL Mutations Below the Detection Limit of Current Standard Screening Techniques Occur Predominantly in the CD34+ Progenitor Cell Compartment in Chronic Phase CML Patients At Diagnosis. A Substudy of the ENEST1st Trial

BCR-ABL Kinase Domain Mutations in the P-Loop and at Imatinib Contact Sites in CML Patients with Imatinib Resistance Are Associated with Higher Maximum Imatinib Doses.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only